Parameters associated with the presence of significant coronary atherosclerosis


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The aim of the study was to fix clinical features associated with the presence of significant coronary atherosclerosis in patients referred for coronary angiography using factor analysis. Material and methods. 336 patients with coronary heart disease (CHD) diagnosis took part in the study. CHD presence was confirmed by diagnostic coronary angiography performing according to the Judkins method with Gensini index calculation. Results. In the group of patients with hemodynamically significant coronary atherosclerosis, the highest values of indicators of oxidative proteins modification (OMP), homocysteine and highly sensitive C-reactive protein (hs-CRP) and the lowest values of heat shock proteins-70 (HSP70) and superoxide dismutase (SOD) activity were found. That indicates the severity of oxidative and cellular stress. According to the results of factor analysis, 6 main factors were identified which explained 75,5% of the total dispersion: endothelial dysfunction factor, constitutional factor, modifiable risk factor, lipid factor, age and prooxidant factor. The first factor turned out to be the most significant. A strong mutual correlation was demonstrated by OMP indicators, homocysteine, SOD, HSP70 and hs-CRP. Conclusion. Use of factor analysis for obtained multivariate data statistical processing made it possible to identify and study the pathogenetic relationships between the variables, determine the most significant criteria for coronary atherosclerosis diagnosis, and calculate the hypothetical values of the selected cumulative factors individually for each patient.

Full Text

Restricted Access

About the authors

Yulia A. Kotova

N.N. Burdenko Voronezh State Medical University of the Ministry of Healthcare of Russia

PhD, associate professor of the Department of outpatient therapy

Anna A. Zuikova

N.N. Burdenko Voronezh State Medical University of the Ministry of Healthcare of Russia

MD, professor, Vice rector for academic affairs, head of the Department of outpatient therapy

Natalia V. Strakhova

N.N. Burdenko Voronezh State Medical University of the Ministry of Healthcare of Russia

PhD, associate professor head of educational Department, associate professor of the Department of outpatient therapy

Olga N. Krasnorutskaya

N.N. Burdenko Voronezh State Medical University of the Ministry of Healthcare of Russia

MD, associate professor dean of the Faculty of general medicine, professor of the Department of outpatient therapy

Elena Yu. Esina

N.N. Burdenko Voronezh State Medical University of the Ministry of Healthcare of Russia

MD, associate professor, professor of the Department of outpatient therapy

References

  1. Суслицына И.Н., Сукманова И.А. Факторы риска и прогнозирование развития инфаркта миокарда у мужчин различных возрастных групп. Российский кардиологический журнал. 2016; 8: 58-63. doi: https://dx.doi.org/10.15829/1560-4071-2016-8-58-63.
  2. Метельская В.А., Гаврилова Н.Е., Яровая Е.А., Бойцов С.А. Интегрированный биомаркер: возможности неинвазивной диагностики коронарного атеросклероза. Российский кардиологический журнал. 2017; 6: 132-138. doi: https://dx.doi.org/10.15829/1560-4071-2017-6-132-138.
  3. Никоненко О.С., Хмуль К.О., Никоненко А.О. с соавт. Прогностическое значение уровней гомоцистеина и витамина Д. у больных ИБС с мультифокальным атеросклерозом. Запорожский медицинский журнал. 2018; 1: 31-35. doi: https://dx.doi.org/10.14739/2310-1210.2018.1.121880.
  4. Пардо П.Г., Венникас О.Р., Кириллова Н.В. Прооксидантный и антиоксидантный статус крови мужчин, перенесших инфаркт миокарда. Клинические и экспериментальные исследования. 2009; 1: 87-89.
  5. Musthafa Q.A., Abdul Shukor M.F., Ismail N.A.S. et al. Oxidative status and reduced glutathione levels in premature coronary artery disease and coronary artery disease. Free Radic Res. 2017; 51(9-10): 787-98. doi: 10.1080/10715762.2017.1379602.
  6. Корок Е.В., Сумин А.Н. Сложности в диагностике обструктивных поражений коронарных артерий: роль неинвазивных тестов. Комплексные проблемы сердечно-сосудистых заболеваний. 2019. 1: 70-79. doi: https://dx.doi.org/10.17802/2306-1278-2019-8-1-70-79
  7. Концевая А.В., Мырзаматова А.О., Драпкина О.М. Биомаркеры в прогнозировании сердечно-сосудистого риска: новые возможности тропонина I. Кардиоваскулярная терапия и профилактика. 2020; 3: 219-226. doi: https://dx.doi.org/10.15829/1728-8800-2020-2584.
  8. Дубинина Е.Е., Бурмистров С.О., Ходов Д.А. Окислительная модификация белков сыворотки крови человека, метод ее определения. Вопросы медицинской химии. 1995; 1: 24-26.
  9. Кузнецов В.А., Ярославская В.И., Горбатенко Е.А. с соавт. Параметры, связанные с отсутствием значимого коронарного атеросклероза, по данным Регистра проведенных операций коронарной ангиографии. Вестник Российской академии медицинских наук. 2013; 9: 27-31. doi: https://dx.doi.org/10.15690/vramn.v68i9.775.
  10. Xie F., Zhan R., Yan L.-C. et al. Diet-induced elevation of circulating HSP70 may trigger cell adhesion and promote the development of atherosclerosis in rats. Cell Stress Chaperones. 2016; 21(5): 907-14. doi: 10.1007/s12192-016-0716-2.
  11. Krepuska M., Szeberin Z., Sotonyi P. et al. Serum level of soluble HSP70 is associated with vascular calcification. Cell Stress Chaperones. 2011; 16(3): 257-65. doi: 10.1007/s12192-010-0237-3.
  12. Stocki P., Wang X.N., Dickinson A.M. Inducible heat shock protein 70 reduces T. cell responses and stimulatory capacity of monocyte-derived dendritis cells. Journal of biological chemistry. 2012; 285(15): 12387-94. doi: 10.1074/jbc.M111.307579.
  13. Безбабичева Т.С. Окислительные стресс как триггер развития атеросклеротической бляшки. Молодежь в науке: новые аргументы сборник научных работ Х. Международного молодежного конкурса. Липецк. 1 марта, 2019 г.: с. 143-147.
  14. Carbone D.L., Doorn J.A., Kiebler Z. et al. Modification of heat shock protein 90 by 4-hydroxynoneneal in a rat model of chronic alcoholic liver disease. The journal of pharmacology and experimental therapeutics. 2005; 315(1): 8-15. doi: 10.1124/jpet.105.088088
  15. Курашова Н.А., Мадаева И.М., Колесникова Л.И. Экспрессия белков теплового шока HSP70 в условиях окислительного стресса. Успехи геронтологии. 2019; 4: 502-508.
  16. Gryszczynska B., Formanowicz D., Budzyn M. et al. Advanced oxidation protein products and carbonylated proteins as biomarkers of oxidative stress in selected atherosclerosis-mediated diseases. Biomed Res Int. 2017; 2017: 4975264. doi: 10.1155/2017/4975264. doi: 10.3390/ijms20163942.
  17. Kassab A., Ajmi T., Issaoui M. et al. Homocysteine enhances LDL fatty acid peroxidation promotion microalbuminuria in type 2 diabetes. Annals of clinical biochemistry. 2008; 45 (Pt 5): 476-80. doi: 10.1258/acb.2007.007125.
  18. Dwivedi M.K., Tripathi A.K., Shukla S. et al. Homocysteine and cardiovascular disease. Biotechnology and molecular biology review. 2011; 5(5): 101-07. doi: 10.5897/BMBR2011.0009.
  19. Weiss N. Mechanisms of increased vascular oxidant stress in hyperhomocysteinemia and its impact on endothelial function. Curr Drug Metab. 2005; 6(1): 27-36. doi: 10.2174/1389200052997357.
  20. Boncler M., Wu Y., Watala C. The multiple faces of C-reactive protein - physiological and pathophysiological implications in cardiovascular disease. Molecules. 2019; 24(1): 1-18. doi: 10.3390/molecules24112062.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies